The Caixin Must-Read newsletter brings you the best of our coverage over the past week, handpicked by our editors.
China’s New Rules on Overseas IPOs Could Make Life Tougher for Foreign Advisors
CSRC’s regulatory framework will subject foreign financial intermediaries to more supervision and fines
In Depth: Major Evergrande Creditor Faces Wave of Bad Loans
Minsheng Bank lent wildly to the property sector for years, with little attention to risk control. Now, it’s battling a rising number of soured loans
Beijing Gears Up for Winter Olympics Amid Omicron Threat
China creates stringent ‘closed loop’ system to isolate competitors and staff from Covid-19 as it demonstrates green technology and builds up winter sports
Property Firms Face Major Debt Squeeze in First Quarter
A record amount of offshore bonds are coming due, while policy easing is yet to have an impact and sales are still low
China’s Tech Giants Take Stakes in More Companies as Crackdown Hits Growth
Tencent, Alibaba and ByteDance look for new ways to boost business as regulators tighten oversight
China’s Commerce Ministry Warns of Challenges to Foreign Investment in 2022
Covid-19 pandemic, changes to global supply chains, among factors contributing to ‘complicated’ international environment, official says
China’s Factories Are Still Indispensable to the U.S.
Demand for Chinese goods will remain strong in 2022 due to weak manufacturing recovery, inflationary pressure, and continuing economic uncertainty in the U.S. due to fresh Covid outbreaks
In Depth: China’s Lagging Expansion of Medical Infrastructure
After the Covid-19 outbreak swamped Wuhan hospitals, China poured billions into construction, but resources are still falling short
In Depth: Fixing the High Cost of Rare Disease Treatment in China
The heavy cost borne by the patients and their caregivers can be financially crippling and sway patients to put off treatment
Tech Regulation Needs to Work in Tandem With Inclusive Growth
Primavera Capital founder Fred Hu and Nobel laureate Michael Spence offer their takes on China’s regulatory crackdown on big tech, its approach to wealth inequality and what cryptocurrencies are good for
Gallery: Amateur’ 70s Ice Hockey Team Reunites
Chinese mRNA Jab Activates 80% to 95% Immune Response
Behind the findings of the homegrown shot’s first stage clinical trials; Beijing’s plan to stay smog-free over the Olympics; and China digests a record amount of bad assets
Related
China’s First mRNA Covid Shot Triggers 80%–95% Immune Response
Caixin Global’s Top Stories of the Month newsletter brings you the most popular news coverage over the past month. You may opt-in now and get handpicked news coverage delivered to your inbox each month for free.
